Evidence map›Paper›PMID 31206972›Full record

ArticleHuman mutation2019

Deleterious de novo variants of X-linked ZC4H2 in females cause a variable phenotype with neurogenic arthrogryposis multiplex congenita.

Suzanna G M Frints, Friederike Hennig, Roberto Colombo, Sebastien Jacquemont, Paulien Terhal, Holly H Zimmerman, David Hunt, Bryce A Mendelsohn, Ulrike Kordaß, Richard Webster and 28 more

Open access · bronzeAbstract read
In one paragraph

Article in Human mutation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. The pathogenic factor of ZC4H2-associated rare disorder is a postsynaptic regulator for synaptic activity and cognitive function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  8. Case Report: A novel missense variant inFrontiers in pediatrics · 2025
    Article
  9. Wieacker-Wolff syndrome with hyperinsulinemic hypoglycemia successfully treated using diazoxide: A case report.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2025
    Article
  10. Article
  11. Article
  12. Loss ofGenes · 2024
    Article
  13. A case of female-restricted Wieacker-Wolff syndrome with heart and endocrinological involvement.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 20 institutions in 10 countries.

Suzanna G M FrintsDepartment of Clinical Genetics, Maastricht University Medical Center+, azM, Maastricht, The Netherlands.ORCID 0000-0002-5027-8364
Friederike HennigResearch Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Roberto ColomboCatholic University of the Sacred Heart, Rome, Italy.
Sebastien JacquemontService de Génétique Médicale, CHUV, Lausanne, Switzerland.
Paulien TerhalLaboratories, Pharmacy and Biomedical Genetics Division, University Medical Centre Utrecht, Utrecht, The Netherlands.
Holly H ZimmermanDepartment of Pediatrics, Division of Medical Genetics, University of Mississippi Medical Center, Jackson, Mississippi.
David HuntWessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Bryce A MendelsohnDivision of Genetics, Department of Pediatrics, University of California, San Francisco, California.
Ulrike KordaßMVZ für Humangenetik und Molekularpathologie GmbH, Greifswald, Germany.
Richard WebsterThe Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Westmead, NSW, Australia.
Margje SinnemaDepartment of Clinical Genetics, Maastricht University Medical Center+, azM, Maastricht, The Netherlands.
Omar Abdul-RahmanMunroe-Meyer Institute for Genetics & Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska.
Vanessa SuckowResearch Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Alberto Fernández-JaénHospital Universitario Quirónsalud, Universidad Europea de Madrid, Madrid, Spain.
Kees van RoozendaalDepartment of Clinical Genetics, Maastricht University Medical Center+, azM, Maastricht, The Netherlands.
Servi J C StevensDepartment of Clinical Genetics, Maastricht University Medical Center+, azM, Maastricht, The Netherlands.ORCID 0000-0001-8769-3150
Merryn V E MacvilleDepartment of Clinical Genetics, Maastricht University Medical Center+, azM, Maastricht, The Netherlands.ORCID 0000-0003-1675-2234
Salwan Al-NasiryDepartment of Obstetrics and Gynecology, Prenatal Diagnostics & Therapy, Maastricht University Medical Center+, Maastricht, The Netherlands.
Koen van GassenLaboratories, Pharmacy and Biomedical Genetics Division, University Medical Centre Utrecht, Utrecht, The Netherlands.
Norbert UtzigKlinik für Kinder- und Jugendmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.
Suzanne M KoudijsDepartment of Neurology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Lesley McGregorSA Clinical Genetics Service, Women's and Children's Hospital, North Adelaide, SA, Australia.
Saskia M MaasDepartment of Clinical Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
Diana BaralleWessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Abhijit DixitCity Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Peter WieackerInstitute of Human Genetics, Westfälische Wilhelms Universität Münster, Münster, Germany.
Marcus LeeDepartment of Pediatrics, Division of Pediatric Neurology, University of Mississippi Medical Center, Jackson, Mississippi.
Arthur S LeeDepartment of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-4513-4630
Elizabeth C EngleDepartment of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-8194-7738
Gunnar HougeDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Gyri A GradekDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Andrew G L DouglasWessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Cheryl LongmanWest of Scotland Regional Genetic Centre, Queen Elizabeth University Hospital, Glasgow, Scotland, UK.
Shelagh JossWest of Scotland Regional Genetic Centre, Queen Elizabeth University Hospital, Glasgow, Scotland, UK.
Danita VelascoDepartment of Pediatrics, Munroe-Meyer Institute for Genetics & Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska.
Raoul C HennekamDepartment of Pediatrics, Amsterdam UMC, Amsterdam, The Netherlands.ORCID 0000-0002-6745-1522
Hiromi HirataDepartment of Chemistry and Biological Science, College of Science and Engineering, Aoyama Gakuin University, Sagamihara, Japan.
Vera M KalscheuerResearch Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0001-6898-3259
Maastricht University · NLMax Planck Institute for Molecular Genetics · DEUniversity Hospital Southampton NHS Foundation Trust · GBAmsterdam University Medical Centers · NLBroad Institute · USHaukeland University Hospital · NONebraska Medical Center · USQueen Elizabeth University Hospital · GBUniversity Medical Center Utrecht · NLUniversity of Mississippi Medical Center · USAoyama Gakuin University · JPChildren's Hospital at Westmead · AUHôpital Orthopédique de la Suisse Romande · CHHospital Universitario Quirónsalud Madrid · ESNottingham University Hospitals NHS Trust · GBSouth Australia Pathology · AUUniversità Cattolica del Sacro Cuore · ITUniversitätsmedizin Greifswald · DEUniversity of California, San Francisco · USUniversity of Münster · DE

Funding

Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
Dissecting ocular congenital cranial dysinnervation disorders through whole genome sequence analysisR01EY027421 · NEI · BOSTON CHILDREN'S HOSPITAL · PI ENGLE, ELIZABETH C. · 2017 to 2021
$3.1M
Department of Health RP-2016-07-011Health Innovation Challenge Fund HICF-1009-003Nederlandse Organisatie voor Wetenschappelijk Onderzoek OND1312421NEI NIH HHS R01 EY027421NEI NIH HHS R01EY027421NHGRI NIH HHS UM1 HG008900NHLBI NIH HHS X01HL132377NICHD NIH HHS U54 HD090255Wellcome and the Department of Health, and the Wellcome Sanger Institute WT098051Wellcome Trust
6 · The paper itself

Abstract

Pathogenic variants in the X-linked gene ZC4H2, which encodes a zinc-finger protein, cause an infrequently described syndromic form of arthrogryposis multiplex congenita (AMC) with central and peripheral nervous system involvement. We present genetic and detailed phenotypic information on 23 newly identified families and simplex cases that include 19 affected females from 18 families and 14 affected males from nine families. Of note, the 15 females with deleterious de novo ZC4H2 variants presented with phenotypes ranging from mild to severe, and their clinical features overlapped with those seen in affected males. By contrast, of the nine carrier females with inherited ZC4H2 missense variants that were deleterious in affected male relatives, four were symptomatic. We also compared clinical phenotypes with previously published cases of both sexes and provide an overview on 48 males and 57 females from 42 families. The spectrum of ZC4H2 defects comprises novel and recurrent mostly inherited missense variants in affected males, and de novo splicing, frameshift, nonsense, and partial ZC4H2 deletions in affected females. Pathogenicity of two newly identified missense variants was further supported by studies in zebrafish. We propose ZC4H2 as a good candidate for early genetic testing of males and females with a clinical suspicion of fetal hypo-/akinesia and/or (neurogenic) AMC.

Indexed as

MutationAnimalsArthrogryposisCodon, NonsenseDisease Models, AnimalFemaleFrameshift MutationGenes, X-LinkedGenetic Predisposition to DiseaseHumansIntracellular Signaling Peptides and ProteinsMaleMutation, MissenseNuclear ProteinsPedigreePhenotypeCodon, NonsenseIntracellular Signaling Peptides and ProteinsNuclear ProteinsZC4H2 protein, humanclub foot/-feetcomplicated spastic paraplegia/ spasticityfetal hypo-/akinesiaXq11.2 microdeletionZC4H2ZC4H2-Associated Rare Disorders (ZARD)

Identifiers

PMID31206972
PMCPMC6874899
OpenAlexW2952177710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.